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LETTER TO THE EDITOR 
 
Cochrane Risk of Bias : ‘Your common man has no conception of the zeal that 




‘Your common man has no conception of the zeal that animates a scientific 
investigator, the fury of contradiction you can arouse in him’.1 As Editors of the 
Cochrane Eyes and Vision group we felt that Professor Wilkins’ somewhat sweeping 
assertion that the Cochrane Risk of Bias tool was not ‘up to the job’ should not go 
unchallenged.2 Those whose interest in systematic reviews has been aroused by 
conflicting views amongst senior academics may wish to read a recent report which 
has systematically synthesised published comments upon the strengths and 
weaknesses of the Cochrane Tool.3 Jørgensen et al. found that the Tool has become 
the standard approach to assess risk of bias in randomized clinical trials but that it has 
frequently been implemented in a non-recommended manner. Inconsistent 
implementation may in part explain the poor agreement rates, which have been 
identified in the use of the tool.4,5 Poor agreement may, however, not matter if the 
reviewer’s conclusions would be the same and the fact that the tool’s configuration 
facilitates checking should not be overlooked. Meta-epidemiological studies have 
proved that studies with inadequate or unclear sequence generation, allocation 
concealment or masking procedures tend to overestimate treatment effects compared 
with trials of adequate quality, especially for subjective outcomes.6,7 What matters in 
the Cochrane Risk of Bias tools is that, despite the fact that agreement in assessing 
trial characteristics may be moderate, its domains are based on constructs that are 
definitely the fundamentals of modern biomedical science. 
 
In their systematic review of the effect of coloured overlays and lenses on reading 
performance, Griffiths et al.8 do not report an explicit statement as to why they chose 
not to conduct a meta-analyses of the included studies. Typical reasons for avoiding 
quantitative synthesis within a systematic review revolve around heterogeneity – the 
included studies being thought to be too different, either statistically or clinically 
(patients, interventions or outcomes).9 In the discussion, Griffiths et al.8 state that 
‘Based upon our view that a large majority of the literature we reviewed is at high risk 
of bias it is not clear that this field of research is ready for meta-analysis’. However, if 
the authors have set inclusion criteria that allow the inclusion of such studies, high risk 
of bias in most studies is a reason for assigning low certainty to the available evidence 
rather than avoiding a meta-analysis. In his comments regarding the Griffiths’ et al.8 
review, Wilkins2 found it inappropriate that the Wilkins Rate of Reading Test was rated 
as ‘High risk of bias’ in an additional domain called ‘External bias’. It is important to 
note that this domain is not part of the Cochrane Risk of Bias tool but was used by the 
review authors to assess a range of issues that include patient sampling and surrogacy 
of outcome measures. In a standard Cochrane review, these issues would be dealt 
with in a following step that leads to the preparation of a Summary of Findings Table 
using GRADE to integrate risk of bias assessment with other dimensions10: 
indirectness, whether the evidence from the included studies is directly relevant to the 
review question in terms of patients, interventions and outcomes; inconsistency, 
whether the effects are consistent across studies; 
imprecision, whether the effects are measured enough precisely to allow an 
unequivocal clinical interpretation of their direction and magnitude; and publication 
bias. In Griffiths’ et al. review,8 the authors consider the use of Wilkins test as providing 
indirect evidence, but this is a clinical, not a methodological decision. Because Griffiths 
et al.8 did not conduct a meta-analysis, but gave no valid reason for not doing so, and 
did not formally assess the certainty of the evidence for dimensions other than risk of 
bias using GRADE, their review is systematic but its analysis is narrative. Narrative 
summaries allow more room for subjectivity and may sometimes be misleading9 
although it is fully acknowledged that quantitative analysis which may capture and 
model uncertainties is not always viable. 
 
Constructive criticism has great value in identifying where improvement in any 
instrument is required but a systematic review of current comments indicates that the 
Tool is very much more than a ‘a set of untraceable opinions of uncertain validity, 
dressed up to look like science’.2 
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